Status:
COMPLETED
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Collaborating Sponsors:
Seoul National University Bundang Hospital
Conditions:
Healthy
Eligibility:
MALE
19-45 years
Phase:
PHASE1
Brief Summary
Phase I clinical trial to compare the pharmacokinetics and safety of CKD-348 with co-administration of CKD-828, D326 and D337 in healthy adult volunteers
Eligibility Criteria
Inclusion
- 19 ≤ age ≤ 45
- Health Volunteers
- Subject who agreeds to participate in this clinical trial voluntarily
Exclusion
- 1\. Subject who cannot participate in a clinical trial based on the PI's judgment
Key Trial Info
Start Date :
June 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 26 2019
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04272502
Start Date
June 4 2019
End Date
August 26 2019
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Gyeonggi-do, South Korea